Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease (March, 10.1038/s41598-022-08794-w, 2022)Manaf AlQahtani,Nitya Kumar,Dhuha Aljawder,Abdulkarim Abdulrahman,Mohammed Wael Mohamed,Fatema Alnashaba,Mohammed Abu Fayyad,Faisal Alshaikh,Fatima Alsahaf,Sawsan Saeed,Amal Almahroos,Zainab Abdulrahim,Sameer Otoom, Stephen L. AtkinSCIENTIFIC REPORTS（2022）引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
